Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Acute Myeloid Leukemia

3 years ago

– FDA lifts partial clinical hold following agreement on mitigation strategy for differentiation syndrome – – KOMET-001 study to resume…

Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA

3 years ago

SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission…

Inventiva announces participation at several conferences in January and February 2022

3 years ago

Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…

EssilorLuxottica : EssilorLuxottica appoints new member to its Board of Directors

3 years ago

EssilorLuxottica appoints new member to its Board of Directors As the new Valoptec Association President, Virginie Mercier Pitre replaces Juliette…

MS Read-a-Thon Makes a Difference in the Lives of Canadians Impacted by MS, One Book at a Time

3 years ago

Long-time fundraiser kicks-off with a virtual book club event, awakening a love for reading in children while supporting the Canadian…

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2021 Financial Results Conference Call

3 years ago

WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its…

Wound Care Commercialization to be a Key Company Focus in 2022

3 years ago

New video blog series part of 2022 commitment to increase and broaden communication to investorsWINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE…

Yingli Pharma and MD Anderson Initiate Strategic Collaboration to Advance Development of Multiple Oncology Programs

3 years ago

Five-year collaboration to provide support for clinical and preclinical efforts as Yingli Pharma expands its U.S. presence with robust oncology…

China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

3 years ago

TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty…

Osmind Announces Appointment of Brent Saunders, Pharma Veteran and Former CEO of Allergan, to Board of Directors

3 years ago

Mr. Saunders will serve on Osmind’s Board of Directors and brings decades of leadership in healthcare and life sciences, including…